An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

Author: AulakhG K, SinghM, SodhiR K

Paper Details 
Original Abstract of the Article :
The renin-angiotensin-aldosterone-system (RAAS) is an important regulator of blood pressure and fluid-electrolyte homeostasis. RAAS has been implicated in pathogenesis of hypertension, congestive heart failure, and chronic renal failure. Aliskiren is the first non-peptide orally active renin inhibit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.lfs.2007.06.007

データ提供:米国国立医学図書館(NLM)

The Renin-Angiotensin-Aldosterone System (RAAS): An Intricate Desert of Blood Pressure Regulation

The renin-angiotensin-aldosterone system (RAAS), a complex network of hormones and enzymes, plays a crucial role in regulating blood pressure, like a finely tuned irrigation system in a desert oasis. This study explores the latest advancements in the development of non-peptide RAAS modulators, drugs that target specific components of this intricate system.

The researchers discuss the potential of various novel compounds, including renin inhibitors, ACE inhibitors, and combined ACE/NEP inhibitors, as potential treatments for hypertension, heart failure, and diabetic nephropathy. They emphasize the importance of understanding the molecular interactions of these drugs with RAAS components, a complex undertaking akin to mapping a vast desert landscape.

A Quest for Precise RAAS Modulation

This research highlights the ongoing quest for precise and effective RAAS modulation, a journey that’s as challenging as navigating a sandstorm.

Seeking a Balance in the Desert

This research reminds us that managing complex physiological systems like RAAS requires a nuanced approach. By understanding the delicate balance of different components, scientists are striving to develop new treatments that are not only effective but also safe and well-tolerated. Just as a skilled desert traveler navigates the changing landscape, researchers are working to find a path toward safer and more effective treatments for heart and kidney disease.

Dr.Camel's Conclusion

This review provides an insightful overview of the latest developments in non-peptide RAAS modulators, highlighting the complexity of this system and the challenges of developing effective treatments. The research emphasizes the need for a nuanced understanding of the interplay between different RAAS components to create safe and effective medications. Just as an experienced desert traveler relies on their knowledge of the terrain to find the right path, scientists are continually exploring the intricate desert landscape of the RAAS system, searching for new ways to manage cardiovascular and kidney disease.
Date :
  1. Date Completed 2007-10-12
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

17692338

DOI: Digital Object Identifier

10.1016/j.lfs.2007.06.007

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.